HB1724 (2025 Regular Session)

HB1724

Prescription Drug Affordability Board; established, drug cost affordability review, report.

What is a Close Vote?

02/18/2025 - Senate: Passed Senate with substitute (26-Y 14-N)
02/19/2025 - House: Senate substitute agreed to by House (52-Y 45-N)

02/18/2025 - Senate: Reconsideration of Senate passage agreed to by Senate
02/18/2025 - Senate: Passed Senate with substitute (26-Y 14-N)

02/18/2025 - Senate: Engrossed by Senate - committee substitute
02/18/2025 - Senate: Passed Senate with substitute (24-Y 16-N)

01/30/2025 - House: Read second time and engrossed
01/31/2025 - House: Read third time and passed House (52-Y 44-N)